Meet the Board Behind One of Today’s Top Precision Medicine Companies
At Kohif Pharmagenix, one of today’s leading precision medicine companies, our board of directors brings together deep clinical, academic, and digital expertise to drive innovation in patient-centered care. From pharmacogenomics to real-time decision support tools, our leadership ensures we remain at the forefront of personalized medicine.
Dr. Mostafa Kohif, PharmD, MSc
CEO & Founder
Visionary Driving Innovation in Pharmacogenomics and Precision Medicine
Dr. Kohif, the founder and CEO of Kohif Pharmagenix, is committed to reshaping healthcare through a comprehensive approach to precision medicine. His journey began with a personal tragedy: the loss of family members due to preventable medication-related harm. This experience led him to envision a platform that integrates genetics, clinical data, drug interactions, comorbidities, and social determinants into one intelligent system.
With an MSc in Precision Medicine from the University of Florida and certifications in Clinical Pharmacogenomics and Cancer Genomics from Harvard Medical School, Dr. Kohif brings both scientific depth and technological insight to the company’s vision. Under his leadership, Kohif Pharmagenix has become a leader in delivering real-time clinical decision support tools that help clinicians make more personalized, effective treatment decisions.
Dr. Paul J. Sorell, MD
Advisory Board Member
Physician, Technologist, and Pioneer in Precision Medicine
As a contemporary physician who thoroughly understands medicine and technology, I’ve been blessed with practicing at the intersection of these two powerful concepts ever since graduating the NYU Grossman School of Medicine. As a clinician in Physical Medicine & Rehabilitation and life-long “techie”, I was instrumental in the process of transitioning from paper to electronic health records. So with the seeds planted, in 2014, well before “big data” was even a thing, I was one of the first adopters of genetically testing my patients to optimize their medication treatment.
It was thus a natural fit when I was invited to join the advisory board of Kohif PharmaGenix. I’ll be bringing my deep understanding of medicine, years of experience in medical affairs, profound expertise in healthcare communications, and first-hand knowledge of digital health to help build the world leader in pharmacogenomic testing—the premier platform that is both easily implemented and clinically relevant. For, at the end of the day, isn’t that what really matters—improving the lives of those for whom we care?
Dr. Leticia Shea, PharmD, BCACP
Advisory Board Member
Advancing Precision Medicine Through Education, Research, and Clinical Expertise
Dr. Leticia Shea is a consultant pharmacist and academic leader with a career spanning clinical practice, scientific communications, and pharmacogenetics education. As a Professor of Pharmacy at Regis University, she has developed innovative pharmacotherapy and pharmacogenetics courses, integrating research and technology to enhance learning and patient care. Dr. Shea’s expertise includes best practices in medication management, precision medicine, pharmacovigilance, and project management, with a proven record of driving process improvements and fostering collaboration among healthcare professionals. Her clinical work at HealthOne Physician Services Group has focused on optimizing medication access, developing clinical decision support tools, and significantly improving medication adherence and safety.
She has authored over 29 peer-reviewed publications and delivered 45 conference presentations, contributing to advancements in medication safety, pharmacogenomics, and health outcomes research. Dr. Shea holds a PharmD from the University of Colorado and an MS in Pharmacogenomics and Precision Medicine from the University of Florida. Her commitment to evidence-based practice and patient-centered care makes her a valued advisor in the evolving field of pharmacogenetics.
Jolene Donald, MSN, APRN, FNP-C, AGACNP-BC, ENP-C
Advisory Board Member
Clinician Leader Uniting Acute Care, Medication Safety, and Genetic Insight
Jolene brings a dynamic frontline perspective to the KOHIF Pharmagenix Advisory Board, drawing from her extensive experience as an Emergency Nurse Practitioner in both urban and rural hospital systems. Board-certified in emergency medicine with dual licensed as a Family Nurse Practitioner and Adult-Gerontology Acute Care Nurse Practitioner, Jolene has firsthand insight into the real-time challenges of medication management in high-acuity settings.
While new to the field of pharmacogenomics, her passion for delivering individualized, evidence-based care aligns seamlessly with Pharmagenix’s mission to optimize therapy through genetic insight. Jolene’s leadership is grounded in a deep commitment to improving patient outcomes, clinical workflow, and provider decision-making, particularly when time and clarity are critical.
Her role on the Advisory Board reflects the company’s dedication to incorporating voices from the bedside into the strategic expansion of PGx in practice. With a strong foundation in acute care and a vision for personalized medicine, Jolene serves as a vital bridge between innovation and clinical reality.
Join One of the Most Innovative Precision Medicine Companies
At Kohif Pharmagenix, innovation isn’t a buzzword, it’s our foundation. With the support of our advisory board and a commitment to clinical utility, we’re building scalable solutions that truly fit the realities of modern care delivery.
Whether you’re a provider, lab, payer, or technology partner, there’s a role for you in this transformation. If you’re seeking to collaborate with one of the most forward-thinking precision medicine companies, let’s shape the future of personalized care together.